Literature DB >> 5918655

Pharmacokinetic model for nalidixic acid in man. II. Parameters for absorption, metabolism, and elimination.

G A Portmann, E W McChesney, H Stander, W E Moore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5918655     DOI： 10.1002/jps.2600550116

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  5 in total

Review 1.  Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure.

Authors:  D E Drayer
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

2.  Probenecid inhibits the renal clearance and renal glucuronidation of nalidixic acid. A pilot experiment.

Authors:  T B Vree; M Van den Biggelaar-Martea; E W Van Ewijk-Beneken Kolmer; Y A Hekster
Journal:  Pharm World Sci       Date:  1993-08-20

3.  Direct gradient reversed-phase HPLC analysis and preliminary pharmacokinetics of nalidixic acid, 7-hydroxymethylnalidixic acid, 7-carboxynalidixic acid, and their corresponding glucuronide conjugates in humans.

Authors:  T B Vree; M van den Biggelaar-Martea; E W van Ewijk-Beneken Kolmer; Y A Hekster
Journal:  Pharm World Sci       Date:  1993-06-18

4.  Pharmacokinetics of nalidixic acid in man: hydroxylation and glucuronidation.

Authors:  T B Vree; W J Wijnands; A M Baars; Y A Hekster
Journal:  Pharm Weekbl Sci       Date:  1988-10-14

5.  Nalidixic acid kinetics in renal insufficiency.

Authors:  G Cuisinaud; N Ferry; N Pozet; P Y Zech; J Sassard
Journal:  Br J Clin Pharmacol       Date:  1982-10       Impact factor: 4.335
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.